These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Landmark Alzheimer's drug approval confounds research community. Mullard A Nature; 2021 Jun; 594(7863):309-310. PubMed ID: 34103732 [No Abstract] [Full Text] [Related]
4. US Food and Drug Administration Approval of Aducanumab-Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials? Planche V; Villain N JAMA Neurol; 2021 Nov; 78(11):1307-1308. PubMed ID: 34515750 [No Abstract] [Full Text] [Related]
5. Alzheimer's drugs take a new tack. Callaway E Nature; 2012 Sep; 489(7414):13-4. PubMed ID: 22962697 [No Abstract] [Full Text] [Related]
6. Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered. Rubin R JAMA; 2021 Aug; 326(6):469-472. PubMed ID: 34287610 [No Abstract] [Full Text] [Related]